Ikarovec

Norwich, United Kingdom · Founded 2018 · Privately Held (backing)

Operator of a gene therapy company intended to treat common eye diseases. Ikarovec is based in Norwich, United Kingdom and was founded in 2018. Its last known valuation is $184 million. It has raised $43.9 million.

Last price · $/share
—
Implied valuation
$184.0M
Total raised
$43.9M
Last round
—
What is Ikarovec worth?
$184.0Mlast known valuation
Free account
More of Ikarovec with a free account
  • ·Watch Ikarovec: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ikarovec funding history

No rounds on record

No funding rounds for Ikarovec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Ikarovec valuation

Ikarovec's last known valuation is $184 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Ikarovec's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ikarovec, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Ikarovec

What is Ikarovec worth?
Ikarovec's last known valuation is $184.0M.
How much has Ikarovec raised?
Ikarovec has raised $43.9M in total funding across its recorded rounds.